Genmab A (GMAB) Change in Acquisitions & Divestments (2023 - 2025)

Genmab A has reported Change in Acquisitions & Divestments for 3 years, with the latest figure at $930.0 million in Q3 2025.

• For the quarter ending Q3 2025, Change in Acquisitions & Divestments fell 32.8% year-over-year to $930.0 million; the trailing twelve-month figure through Sep 2025 stood at $3.4 billion (down 21.72% YoY), and the FY2024 full-year result was $1.6 billion, up 12.75% from the prior year.
• Change in Acquisitions & Divestments for Q3 2025 stood at $930.0 million, up from $595.0 million in the prior quarter.
• The five-year high for Change in Acquisitions & Divestments was $1.6 billion in Q4 2024, with the low at $259.0 million in Q1 2025.
• Historically, Change in Acquisitions & Divestments has averaged $973.6 million across 3 years, with a median of $1.0 billion in 2024.
• Annual changes were most pronounced in 2024 — Change in Acquisitions & Divestments climbed 12.75% — and 2025, when it sank 44.75%.
• Genmab A's Change in Acquisitions & Divestments stood at $1.5 billion in 2023, then rose by 12.75% to $1.6 billion in 2024, then tumbled by 43.15% to $930.0 million in 2025.
• The last three Change in Acquisitions & Divestments figures came in at $930.0 million (Q3 2025), $595.0 million (Q2 2025), and $259.0 million (Q1 2025), per Business Quant data.